Staffing & Employment Services
Compare Stocks
2 / 10Stock Comparison
TBI vs HSII
Revenue, margins, valuation, and 5-year total return — side by side.
Staffing & Employment Services
TBI vs HSII — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Staffing & Employment Services | Staffing & Employment Services |
| Market Cap | $182M | $1.23B |
| Revenue (TTM) | $1.25B | $1.21B |
| Net Income (TTM) | $-53M | $37M |
| Gross Margin | 28.4% | 23.3% |
| Operating Margin | -2.6% | 3.0% |
| Forward P/E | — | 16.7x |
| Total Debt | $171M | $101M |
| Cash & Equiv. | $25M | $516M |
TBI vs HSII — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| TrueBlue, Inc. (TBI) | 100 | 38.9 | -61.1% |
| Heidrick & Struggle… (HSII) | 100 | 265.4 | +165.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TBI vs HSII
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TBI is the clearest fit if your priority is momentum.
- +51.0% vs HSII's +46.2%
HSII carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.76, yield 1.0%
- Rev growth 7.2%, EPS growth -84.4%, 3Y rev CAGR 3.4%
- 240.0% 10Y total return vs TBI's -68.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.2% revenue growth vs TBI's 3.1% | |
| Quality / Margins | 3.1% margin vs TBI's -4.3% | |
| Stability / Safety | Beta 0.76 vs TBI's 1.13, lower leverage | |
| Dividends | 1.0% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +51.0% vs HSII's +46.2% | |
| Efficiency (ROA) | 2.9% ROA vs TBI's -8.1%, ROIC 6.0% vs -5.2% |
TBI vs HSII — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TBI vs HSII — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
HSII leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
TBI and HSII operate at a comparable scale, with $1.2B and $1.2B in trailing revenue. HSII is the more profitable business, keeping 3.1% of every revenue dollar as net income compared to TBI's -4.3%. On growth, HSII holds the edge at +14.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.2B | $1.2B |
| EBITDAEarnings before interest/tax | -$10M | $57M |
| Net IncomeAfter-tax profit | -$53M | $37M |
| Free Cash FlowCash after capex | -$60M | $132M |
| Gross MarginGross profit ÷ Revenue | +28.4% | +23.3% |
| Operating MarginEBIT ÷ Revenue | -2.6% | +3.0% |
| Net MarginNet income ÷ Revenue | -4.3% | +3.1% |
| FCF MarginFCF ÷ Revenue | -4.8% | +10.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | +14.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -37.5% | +16.9% |
Valuation Metrics
TBI leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, HSII's 30.8x EV/EBITDA is more attractive than TBI's 160.0x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $182M | $1.2B |
| Enterprise ValueMkt cap + debt − cash | $329M | $812M |
| Trailing P/EPrice ÷ TTM EPS | -3.73x | 143.93x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.72x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 160.03x | 30.78x |
| Price / SalesMarket cap ÷ Revenue | 0.11x | 1.10x |
| Price / BookPrice ÷ Book value/share | 0.65x | 2.76x |
| Price / FCFMarket cap ÷ FCF | — | 9.88x |
Profitability & Efficiency
HSII leads this category, winning 8 of 8 comparable metrics.
Profitability & Efficiency
HSII delivers a 7.3% return on equity — every $100 of shareholder capital generates $7 in annual profit, vs $-19 for TBI. HSII carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to TBI's 0.62x. On the Piotroski fundamental quality scale (0–9), HSII scores 6/9 vs TBI's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -18.7% | +7.3% |
| ROA (TTM)Return on assets | -8.1% | +2.9% |
| ROICReturn on invested capital | -5.2% | +6.0% |
| ROCEReturn on capital employed | -5.3% | +1.1% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 |
| Debt / EquityFinancial leverage | 0.62x | 0.22x |
| Net DebtTotal debt minus cash | $146M | -$415M |
| Cash & Equiv.Liquid assets | $25M | $516M |
| Total DebtShort + long-term debt | $171M | $101M |
| Interest CoverageEBIT ÷ Interest expense | -46.19x | — |
Total Returns (Dividends Reinvested)
HSII leads this category, winning 4 of 5 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HSII five years ago would be worth $14,577 today (with dividends reinvested), compared to $2,130 for TBI. Over the past 12 months, TBI leads with a +51.0% total return vs HSII's +46.2%. The 3-year compound annual growth rate (CAGR) favors HSII at 34.9% vs TBI's -26.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +36.6% | — |
| 1-Year ReturnPast 12 months | +51.0% | +46.2% |
| 3-Year ReturnCumulative with dividends | -60.2% | +145.7% |
| 5-Year ReturnCumulative with dividends | -78.7% | +45.8% |
| 10-Year ReturnCumulative with dividends | -68.4% | +240.0% |
| CAGR (3Y)Annualised 3-year return | -26.4% | +34.9% |
Risk & Volatility
HSII leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HSII is the less volatile stock with a 0.76 beta — it tends to amplify market swings less than TBI's 1.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HSII currently trades 99.9% from its 52-week high vs TBI's 77.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.13x | 0.76x |
| 52-Week HighHighest price in past year | $7.78 | $59.05 |
| 52-Week LowLowest price in past year | $3.18 | $39.84 |
| % of 52W HighCurrent price vs 52-week peak | +77.2% | +99.9% |
| RSI (14)Momentum oscillator 0–100 | 83.2 | 77.9 |
| Avg Volume (50D)Average daily shares traded | 386K | 0 |
Analyst Outlook
HSII leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates TBI as "Buy" and HSII as "Hold". Consensus price targets imply -0.0% upside for HSII (target: $59) vs -4.3% for TBI (target: $6). HSII is the only dividend payer here at 1.03% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $5.75 | $59.00 |
| # AnalystsCovering analysts | 10 | 5 |
| Dividend YieldAnnual dividend ÷ price | — | +1.0% |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | — | $0.61 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | +0.3% |
HSII leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TBI leads in 1 (Valuation Metrics).
TBI vs HSII: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is TBI or HSII a better buy right now?
For growth investors, Heidrick & Struggles International, Inc.
(HSII) is the stronger pick with 7. 2% revenue growth year-over-year, versus 3. 1% for TrueBlue, Inc. (TBI). Heidrick & Struggles International, Inc. (HSII) offers the better valuation at 143. 9x trailing P/E (16. 7x forward), making it the more compelling value choice. Analysts rate TrueBlue, Inc. (TBI) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — TBI or HSII?
Over the past 5 years, Heidrick & Struggles International, Inc.
(HSII) delivered a total return of +45. 8%, compared to -78. 7% for TrueBlue, Inc. (TBI). Over 10 years, the gap is even starker: HSII returned +240. 0% versus TBI's -68. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — TBI or HSII?
By beta (market sensitivity over 5 years), Heidrick & Struggles International, Inc.
(HSII) is the lower-risk stock at 0. 76β versus TrueBlue, Inc. 's 1. 13β — meaning TBI is approximately 49% more volatile than HSII relative to the S&P 500. On balance sheet safety, Heidrick & Struggles International, Inc. (HSII) carries a lower debt/equity ratio of 22% versus 62% for TrueBlue, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — TBI or HSII?
By revenue growth (latest reported year), Heidrick & Struggles International, Inc.
(HSII) is pulling ahead at 7. 2% versus 3. 1% for TrueBlue, Inc. (TBI). On earnings-per-share growth, the picture is similar: TrueBlue, Inc. grew EPS 61. 4% year-over-year, compared to -84. 4% for Heidrick & Struggles International, Inc.. Over a 3-year CAGR, HSII leads at 3. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — TBI or HSII?
Heidrick & Struggles International, Inc.
(HSII) is the more profitable company, earning 0. 8% net margin versus -3. 0% for TrueBlue, Inc. — meaning it keeps 0. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HSII leads at 0. 7% versus -1. 7% for TBI. At the gross margin level — before operating expenses — HSII leads at 25. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is TBI or HSII more undervalued right now?
Analyst consensus price targets imply the most upside for HSII: -0.
0% to $59. 00.
07Which pays a better dividend — TBI or HSII?
In this comparison, HSII (1.
0% yield) pays a dividend. TBI does not pay a meaningful dividend and should not be held primarily for income.
08Is TBI or HSII better for a retirement portfolio?
For long-horizon retirement investors, Heidrick & Struggles International, Inc.
(HSII) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 76), 1. 0% yield, +240. 0% 10Y return). Both have compounded well over 10 years (HSII: +240. 0%, TBI: -68. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between TBI and HSII?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
HSII pays a dividend while TBI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.